ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 87 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,722 | -27.5% | 3,901 | +9.7% | 0.00% | -50.0% |
Q2 2023 | $36,876 | +60.8% | 3,556 | +25.5% | 0.00% | +100.0% |
Q1 2023 | $22,927 | -66.7% | 2,834 | -35.2% | 0.00% | -66.7% |
Q4 2022 | $68,891 | +20.6% | 4,374 | +20.5% | 0.00% | 0.0% |
Q3 2022 | $57,120 | +12.7% | 3,629 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $50,661 | -1.9% | 3,629 | +21.1% | 0.00% | 0.0% |
Q1 2022 | $51,651 | -72.0% | 2,996 | -76.4% | 0.00% | -33.3% |
Q4 2021 | $184,600 | -19.2% | 12,696 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $228,528 | +2.5% | 12,696 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $222,942 | +149.8% | 12,696 | +5.1% | 0.00% | +50.0% |
Q4 2018 | $89,256 | -44.4% | 12,078 | +9.2% | 0.00% | -33.3% |
Q3 2018 | $160,533 | -99.9% | 11,056 | 0.0% | 0.00% | -25.0% |
Q2 2018 | $220,788,000 | +68.8% | 11,056 | +48.1% | 0.00% | +100.0% |
Q1 2018 | $130,821,000 | +70998.4% | 7,467 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $184,000 | -50.4% | 7,467 | -48.1% | 0.00% | 0.0% |
Q3 2017 | $371,000 | -4.9% | 14,374 | 0.0% | 0.00% | -33.3% |
Q2 2017 | $390,000 | +62.5% | 14,374 | +78.3% | 0.00% | +50.0% |
Q1 2017 | $240,000 | +9.6% | 8,061 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $219,000 | +6.3% | 8,061 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $206,000 | – | 8,061 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,808,034 | $29,119,313 | 14.32% |
Foresite Capital Management V, LLC | 1,258,243 | $13,047,980 | 9.53% |
GREAT POINT PARTNERS LLC | 1,941,581 | $20,134,195 | 3.94% |
Bain Capital Life Sciences Investors, LLC | 3,400,000 | $35,258,000 | 3.63% |
Aisling Capital Management LP | 434,455 | $4,505,298 | 2.21% |
SILVERARC CAPITAL MANAGEMENT, LLC | 651,400 | $6,755,018 | 2.09% |
VR Adviser, LLC | 1,040,754 | $10,792,619 | 1.73% |
Ikarian Capital, LLC | 796,300 | $8,257,631 | 1.32% |
Samsara BioCapital, LLC | 696,171 | $7,219,293 | 1.27% |
BRAIDWELL LP | 2,901,194 | $30,085,382 | 0.98% |